Unlock the full potential of Medical Affairs teams in the pharmaceutical industry to address complex challenges and lead strategic decision-making.
Tag: Medical Affairs
PROs: Can patients ‘co-develop’ their treatment?
Discover the value of patient-reported outcomes (PROs) in clinical trials and how they can help address unmet needs in ovarian cancer.
How to measure the value of Medical Affairs teams
Discover how to redefine qualitative and quantitative metrics in Medical Affairs to improve patient outcomes whilst demonstrating value to the organisation.